Schedule 13G ownership disclosure

Ocera Therapeutics, Inc.

Security class unavailable · CUSIP: 67552A108

Event date: 2017-03-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,150,000
Percent of class
9.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000370
Form type
SC 13G
Filer
Ocera Therapeutics, Inc.
CIK
CIK 1274644
Filed
Apr 17, 2017
Reporting period
Mar 08, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub